PFE
Pfizer Inc
27.70$
+0.1%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 26.8% | 26.9% | 30.2% | 30.0% | 29.8% | 30.7% | 28.3% | 42.3% | 38.1% | 49.1% | 34.2% | 29.7% | |
| 73.2% | 73.1% | 69.8% | 70.0% | 70.2% | 69.3% | 71.7% | 57.7% | 61.9% | 50.9% | 65.8% | 70.3% | |
| 16.8% | 15.7% | 14.8% | 14.5% | 14.9% | 20.3% | 22.6% | 17.0% | 11.4% | 17.8% | 16.9% | 19.1% | |
| 22.2% | 24.0% | 22.0% | 22.2% | 21.9% | 29.3% | 23.6% | 13.2% | 10.8% | 18.6% | 18.0% | 21.8% | |
| 44.9% | 45.8% | 42.8% | 42.6% | 41.7% | 51.1% | 49.9% | 32.1% | 24.5% | 42.1% | 39.9% | 45.7% | |
| 28.3% | 27.2% | 27.0% | 27.4% | 28.5% | 18.2% | 21.8% | 25.6% | 37.4% | 8.9% | 25.9% | 24.7% | |
| 2.7% | 2.5% | 2.2% | 2.4% | 2.5% | 3.8% | 3.5% | 1.6% | 1.2% | 3.7% | 4.9% | 4.3% | |
| 24.7% | 18.4% | 15.8% | 23.4% | 22.2% | 27.9% | 16.9% | 29.9% | 34.6% | 1.8% | 12.6% | 12.0% | |
| 6.3% | 4.1% | 2.1% | -17.2% | 1.3% | 1.5% | 0.9% | 2.3% | 3.3% | -1.9% | 0.0% | -0.4% | |
| 18.3% | 14.3% | 13.7% | 40.5% | 20.8% | 39.5% | 22.0% | 27.2% | 31.3% | 3.6% | 12.6% | 12.4% | |
| 38.6% | 31.4% | 29.0% | 37.8% | 36.5% | 45.8% | 31.6% | 37.9% | 40.9% | 16.0% | 28.5% | 24.1% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.